Voie d'immunisation et séquence d'administration de l ... - TEL

Voie d'immunisation et séquence d'administration de l ... - TEL Voie d'immunisation et séquence d'administration de l ... - TEL

tel.archives.ouvertes.fr
from tel.archives.ouvertes.fr More from this publisher
27.06.2013 Views

tel-00827710, version 1 - 29 May 2013 Fig.1. Schematic representation of purified biotinylated MHC Class I molecule (left) and multimer (right) (adapted from Klenerman et al. (9)). 228

tel-00827710, version 1 - 29 May 2013 Fig.2. Schematic representation of the enrichment procedure. Starting from cellular suspension, cells are stained with PE-labeled multimer, then incubated with antiPE-microbeads before loading on a MACS column. Flow through is the Depleted fraction. By removing the column, you then have access to your Enriched fraction, containing increased numbers of multimer-positive cells. Page 229 of 256

tel-00827710, version 1 - 29 May 2013<br />

Fig.2. Schematic representation of the enrichment procedure. Starting from cellular suspension, cells are stained<br />

with PE-labeled multimer, then incubated with antiPE-microbeads before loading on a MACS column. Flow<br />

through is the Depl<strong>et</strong>ed fraction. By removing the column, you then have access to your Enriched fraction,<br />

containing increased numbers of multimer-positive cells.<br />

Page 229 of 256

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!